NYX-2925   Click here for help

GtoPdb Ligand ID: 11289

Synonyms: NYX2925
Compound class: Synthetic organic
Comment: NYX-2925 is a oral, brain-penetrating, NMDA receptor modulator that was developed by Aptinyx [2]. It acts as a co-agonist to glutamate and partially activates NMDARs. NYX-2925 is being investigated for potential to modulate neural pathways relevant for chronic pain.
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 7
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 103.94
Molecular weight 297.17
XLogP -1.69
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CC(C(=O)N1CCC[C@@]21CN(C2=O)[C@H](C(=O)N)[C@H](O)C)C
Isomeric SMILES CC(C(=O)N1CCC[C@@]21CN(C2=O)[C@H](C(=O)N)[C@H](O)C)C
InChI InChI=1S/C14H23N3O4/c1-8(2)12(20)17-6-4-5-14(17)7-16(13(14)21)10(9(3)18)11(15)19/h8-10,18H,4-7H2,1-3H3,(H2,15,19)/t9-,10+,14-/m1/s1
InChI Key NFXPEHLDVKVVKA-ISTVAULSSA-N
Bioactivity Comments
NYX-2925 facilitates [3H]MK-801 (dizocilpine) binding at all four human NMDAR2 subtypes [2].
Selectivity at ion channels
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
GluN2A Hs Allosteric modulator Positive 10.3 pEC50 - 2
pEC50 10.3 (EC50 5.5x10-11 M) [2]
Description: Potentiation of glycine site agonist MK-801 binding to human N-methyl-D-aspartate receptor NR2A-D subtypes expressed in HEK cells.